This book provides a collection of valuable reviews on the major inflammatory cells involved in airways disease and examines the pharmacology of current anti-inflammatory drugs used in the treatment of airways disease. Moreover, an insight into the development of emerging drug therapies is also highlighted.
This book is a must for the library of any researcher or clinician interested in the pathophysiology of airways disease.
Table of Contents
Contents. List of Contributors. Preface. Peter K. Jeffery: Pathological spectrum of airway inflammation. Gianni Marone, Anna Ciccarelli,
Giuseppe Spadaro and Anna Maria Onorati: Role of basophils in airways inflammation. Paolo Gresele and Roberta Vezza: Platelets. Moira Whyte:
Neutrophils. Anthony J. Coyle, Jose Carlos Gutierrez-Ramos: Eosinophils in asthma. Ian A. Akers, Robin J. McAnulty and Geoffrey J. Laurent:
Fibroblasts and myofibroblasts. Elaine Lee and Stephen A. Kilfeather:
Airway macrophages and dendritic cells. Anne Burke-Gaffney and Paul G.
Hellewell: Contribution of endothelial cells to airway inflammation.
Jagdish Laxman Devalia, Jia Hua Wang and Robert James Davies: Airway epithelial cells. Alastair G. Stewart, Darren J. Fernandes, Valentina Kalafatis, Aurora Messina, Claire E. Ravenhall, Ross Vlahos and Kai-Feng Xu: Airway smooth muscle cells. K. H. Banner, D. Spina and C. P. Page:
Drugs that reduce airways inflammation. D. M. Kemeny and B. J. ÒConnor:
T cells in the lung. Index.